The Board of Supervisors of the US city of San Francisco is calling fora meeting on April 12, at which it will propose that no city property should carry "sexy" advertising for HIV/AIDS drugs. This would make San Francisco the first US city to impose such a ban.
Given the increasing rates of HIV infection, city officials and activists are noting their concern at what they see as the ads' "glamorization" of prescription drugs. This type of advertising "sends a message that if you get infected, just take a pill and you'll be beautiful and happy," San Francisco Board of Supervisors president Tom Ammiano told Reuters.
Preliminary results of a study of men seeking treatment for sexually-transmitted diseases at public clinics found that "treatment optimism" might be a reason for San Francisco's rising levels of new HIV infection, with 71% of respondents finding the ads depicted men who were "healthy, handsome and strong," and 61% saying that such advertising could affect a decision to have unprotected sex. "These drug ads are using sex to sell HIV medicines, which is like using [hamburgers] to sell cholesterol medicine," said study author, Jeff Klausner.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze